The hypothesis that local changes in extracellular calcium may serve a physiological role in regulating osteoblast, osteoclast, and cartilage function through the extracellular cation-sensing receptor, CasR, is gaining widespread support, but lacks definite proof. To examine the effects of CasR deficiency on the skeleton, we performed a detailed analysis of the skeleton in CasR knockout mice (CasR Ϫ/Ϫ ) and wild-type littermates (CasR ϩ/ϩ ). CasR ablation in the parathyroid glands of CasR Ϫ/Ϫ mice resulted in hyperparathyroidism, hypercalcemia, and hypophosphatemia. Except for dwarfism, the expected skeletal manifestations of PTH excess, namely chondrodysplasia and increased mineralized bone formation and resorption, were not the main skeletal features in CasR 
T HE CATION-SENSING receptor (CasR), the prototypic G protein-coupled extracellular Ca 2ϩ -sensing receptor, is a member of the class C family of G protein-coupled receptors, which includes metabotropic glutamate, ␥-aminoisobutyric acid, and pheromone receptors (1, 2) . Extracellular calcium is the major ligand for CasR function, and the predominant physiological function of CasR is to regulate PTH secretion and parathyroid hyperplasia in response to changes in extracellular calcium. The central role of CasR in systemic calcium homeostasis is supported by the presence of inactivating mutations of CasR in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism (3) , and activating mutations resulting in hypoparathyroidism (4) . In addition, targeted ablation of CasR results in hypercalcemia and elevated PTH levels in mice (5) .
CasR also has been isolated and cloned from kidney (6) and brain (7) cDNA libraries and is purported to be present in many other tissues, including the skeleton, where its physiological role remains to be identified (1) . There is a growing body of evidence that extracellular calcium concentrations in the bone microenvironment could play a physiological role in modulating bone remodeling through activation of CasR or a functionally similar, but molecularly distinct, receptor in the skeleton (1, 8 -10) . In this model, Ca 2ϩ released from the process of bone resorption is postulated to participate in feedback inhibition of osteoclast-mediated bone resorption and stimulation of osteoblast recruitment and osteoblastmediated bone formation to replace the bone lost from the previous resorption cycle. A role for calcium sensing in the skeleton is largely supported by indirect evidence. For example, CasR has been variably reported to be expressed in osteoblasts (1, (11) (12) (13) , bone marrow stromal cells (11) , osteoclasts (12) , and monocyte-macrophages (13) . In addition, the presence of high ambient Ca 2ϩ concentrations (8 -40 mm) at sites of bone resorption is consistent with this hypothesis (14) . Moreover, CasR has been reported to stimulate preosteoblastic and/or stromal cell proliferation (11, 15, 16) and to inhibit osteoclastogenesis (12) . Others have detected CasR in hypertrophic chondrocytes by in situ hybridization and have demonstrated inhibition of functional responses of cultured chondrocytes to extracellular cations by transfecting antisense CasR constructs (17, 18) . Thus, CasR or a related receptor may provide a means by which alterations in mineral homeostasis in the skeleton may directly regulate bone as well as cartilage function.
Definitive in vivo evidence, however, is lacking for a direct physiological role of calcium in the skeleton that is mediated by an extracellular calcium-sensing G protein-coupled receptor. Despite the fact that inactivating CasR mutations in neonatal severe hyperparathyroidism are associated with skeletal manifestations characterized by fractures, these changes have been attributed to hyperparathyroidism, which is indirectly caused by loss of CasR in parathyroid glands (3) . Similarly, administration of CasR antagonist to rats causes an increase in circulating PTH levels and bone turnover, but no net change in bone mineral density or disruption in osteoblasts coupling to osteoclasts, as might be expected if CasR is playing a direct role in regulating bone remodeling (19) . Targeted deletion of CasR in mice results in growth retardation (5), but to date no studies in these mice have characterized the abnormalities of bone and cartilage in sufficient detail to uncover potential direct consequences of CasR deficiency on the skeleton.
In an effort to identify a function role for calcium-sensing receptors in bone and cartilage in vivo, we evaluated the skeletal phenotype of CasR knockout mice. We observed the unexpected development of severe rickets in mice lacking the CasR rather than the anticipated PTH-mediated skeletal changes. Thus, analogous to the central function of the parathyroid CasR in controlling systemic calcium homeostasis, our studies support the concept that skeletal calcium-sensing receptors may provide a mechanism by which extracellular calcium in the bone microenvironment can directly regulate the mineralization process. Proof of this possibility requires additional studies to remove the confounding effects of excess PTH and hypercalcemia.
Materials and Methods Mice
We obtained heterozygotic mice (CasR ϩ/Ϫ ) with targeted disruptions of exon 5 of the CasR gene (5) 
Genotyping
We used a PCR approach to genotype the mice as previously described (19) , using the reverse primer CasR 2144.R (5Ј-TGAAGCAC-CTACGGCACCTG-3Ј) specific for the native mouse CasR gene sequence in combination with a primer designed to upstream elements in exon 5, CasR 1956.F (5Ј-TGATGAAGAGTCTTTCTCGG-3Ј), or a primer KCM-F (5Ј-TCTTGATTCCCACTTTGTGGTTCTA-3Ј) to the inserted neomycin gene sequence used for targeted disruption of exon 5 (19) .
RT-PCR analysis of CasR transcripts in mouse tissues
To detect CasR expression, RT-PCR was performed using the Titan One Tube RT-PCR Kit (Roche, Indianapolis, IN). Total RNAs were prepared from mouse kidney, cartilage, bone marrow, and bone tissue using the TRIzol reagent (Life Technologies, Inc.) as described previously (20) . Cartilage was obtained by dissecting away the growth plate from metaphyseal bone in 4-d-old wild-type mice. To separate bone and bone marrow, the epiphyses from adult wild-type bone were removed with a scalpel, and the bone marrow was collected by repeated flushing with HBSS. The remaining bone shaft was pulverized in liquid nitrogen before RNA extraction.
The RT reaction using 2.0 g total RNA treated with deoxyribonuclease I (Stratagene, La Jolla, CA) was incubated at 45 C for 60 min, and the template was denatured at 94 C for 2 min. PCR was performed with thermal cycling parameters of 94 C for 30 s, 55 C for 30 s, and 68 C for 45 s for 10 cycles. This was followed by an additional 25 cycles with thermal cycling parameters of 94 C for 30 s, 55 C for 30 s, and 68 C for 45 s plus an additional 5 s with each cycle. The reaction was completed with a final extension at 68 C for 7 min. The mouse specific intronspanning primer sets used to amplify the regions of the 5Ј-end of mouse CasR included the mouse-specific forward primer mCasR 640.For (5Ј-CAGCGAGCCCAAAAGAAAGG-3Ј) and mCasR 1553.Rev (5Ј-CTTCA-GACCGAACCCAATGG-3Ј). To amplify a region containing the 3Ј-end of CasR, we used the forward primer mCasR 2150.F (5Ј-GGAAGATCT-TGTGGAGTGGG-3Ј and reverse primer mCasR 2945.R (5Ј-GCAAA-GAAGAAGCAGATGGC-3Ј). In addition, using a similar protocol (19) , the mouse G3PDH transcript was RT-PCR-amplified as a control using the forward primer G3PDH.F (5Ј-GACCCCTTCATTGACCTCAAC-TACA-3Ј) and the reverse primer G3PDH.R (5Ј-GGTCTTACTCCTTG-GAGGCCATGT-3Ј). The mouse osteocalcin transcript was RT-PCRamplified using the forward primer mOGϩ8.F (5Ј-CAAGTCCCACA-CAGCAGCTT-3Ј) and the reverse primer mOGϩ378.R (5Ј-AAAGC-CGAGCTGCCAGAGTT-3Ј). Amplification products were resolved by electrophoresis on a 1.5% agarose gel and visualized by ethidium bromide staining.
Serum biochemistries
Blood was obtained from 4-to 6-d-old mice. Urine was collected from sodium pentobarbital-anesthetized 4-to 6-d-old mice by aspiration from the bladder with a 27-gauge needle and tuberculin syringe. Calcium was measured by the colorimetric cresolphthalein-binding method, and phosphorus was measured by the phosphomolybdate-ascorbic acid method (21) . Creatinine was measured by the colorimetric alkaline picrate method (Sigma kit 555, Sigma, St. Louis, MO). PTH was measured using the rat PTH immunoradiometric assay from Immutopics, Inc. (San Clemente, CA), which has been previously validated for mouse PTH (22) .
Dry and ash weights of femurs
and CasRϪ/Ϫ (n ϭ 6) mice were cleaned of muscle and dried to constant weight at 110 C. The dried femurs were ashed overnight at 600 C and weighed. The results are expressed as a ratio of ashed to dry weight. This value represents the total bone mineral content (23) .
Skeleton staining
Whole mouse carcasses were collected from CasR ϩ/ϩ (n ϭ 6), CasR ϩ/-(n ϭ 12), and CasR Ϫ/Ϫ (n ϭ 7) mice after they were killed by sodium pentobarbital overdose, skinned, eviscerated, and fixed for more than 3 d in 95% ethanol. They were then defatted for 2-3 d in acetone and stained sequentially with Alcian blue and Alizarin red S in 2% KOH (24) . The stained skeleton preparations were cleared with 1% KOH/20% glycerol and stored in 50% ethanol/50% glycerol (25) .
Quantitative histomorphometric analysis of nondecalcified bone
Skeletons of CasR ϩ/ϩ , CasR ϩ/Ϫ , and CasR Ϫ/Ϫ mice were prelabeled with calcein (Sigma C-0875; 30 g/g BW, sc injection) 1 and 3 d before collection of tibias. Femurs and tibias were removed from 5-d-old CasR ϩ/ϩ , CasR ϩ/Ϫ , and CasR Ϫ/Ϫ mice, fixed in 70% ethanol, prestained in Villanueva stain (26) , and processed for methyl methacrylate embedding. We also collected bone samples from 2-d-old mice that were not prelabeled. Five-micron sections were stained with either Toluidine blue or Goldner's stain and analyzed under transmitted light, and 10-m Villanueva-prestained sections were evaluated under fluorescent light as previously reported by our laboratory (27) . The histomorphometric examination was performed with an Osteomeasure digitizing system (OsteoMetrics, Inc., Atlanta, GA) using a drawing tube attached to a microscope. Growth plate measurements were performed at a magnification of ϫ40, whereas measurement of the bone secondary spongiosa was performed at a magnification of ϫ400. The terminology and units used are those recommended by the histomorphometry nomenclature committee of the American Society of Bone and Mineral Research (28) . RZ.Th, PZ.TH., and HZ.Th are the abbreviations used for the resting, proliferative, and hypertrophic zones of the growth plate cartilage, respectively. BV/TV represents the trabecular bone volume of the secondary spongisa; OV/BV is the relative osteoid volume; OS/BS is the percentage of bone surfaces covered with osteoid; O.Th. is the osteoid seam width; Ob/Bs is the osteoblast perimeter; ES/BS is the resorptive perimeter; N.Oc is the number of osteoclasts per bone perimeter; MAR represents the adjusted mineral apposition rate; MLT is the mineralization lag time, MS/OS represents the mineralizing osteoid; BFR represents the surface referenced bone formation rate.
Skeletal radiography
Five-day-old mice were radiographed using a Hewlett-Packard Faxitron 43807 (Palo Alto, CA) and X-Omat film (Eastman Kodak Co., Rochester, NY).
Statistics
We evaluated differences between groups by one-way ANOVA. All values are expressed as the mean Ϯ sem. All computations were performed using the Statgraphic statistical graphics system (STSC, Inc., Rockville, MD).
Results

Gross skeletal phenotype
The mortality of the CasR Ϫ/Ϫ mice was extremely high, with very few knockout mice surviving beyond 7 d of age. For this reason, we predominantly studied 2-to 6-d-old animals. CasR ϩ/ϩ , CasR Ϫ/ϩ , and CasR Ϫ/Ϫ were grossly indistinguishable at birth. Using body weight as an index of growth, the respective birth weights (mean Ϯ sem) were 1. (Table 1) and showed an obvious reduction in the size of the skeleton (Fig. 1) . Comparison of skeletal radiographs of CasR ϩ/ϩ and CasR Ϫ/Ϫ littermates ( Fig. 1, C vs. D) demonstrated a more radiolucent skeleton in CasR Ϫ/Ϫ mice. In addition, the epiphyseal cartilage of the wrist was wider, the mineralization of the os calcis decreased, and the number of mineralized caudal vertebrae was less than those in the wildtype CasR ϩ/ϩ littermates. The apparent decrease in mineralization of the skeleton in the CasR Ϫ/Ϫ mice was confirmed by a significantly reduced bone ash (Table 1 ). In CasR ϩ/Ϫ mice the radiographic appearance of the skeleton (data not shown), growth, and dry ashed weight of bone (Table 1) were identical to those in CasR ϩ/ϩ mice.
Serum biochemistry
As expected from the loss of parathyroid gland CasR, CasR-deficient mice have an extremely high circulating concentration of PTH (ϳ90-fold increase compared with wildtype controls) accompanied by a modest, but significant, increase in serum total Ca and a decreased serum inorganic P. The effects of the elevated PTH are also evident on urinary excretion of calcium, which was decreased in CasR Ϫ/Ϫ compared with CasR ϩ/ϩ mice. We were unable to detect differences in serum PTH, calcium, or phosphorus or urinary calcium excretion in CasR ϩ/-compared with CasR ϩ/ϩ controls (Table 1) .
Endochondral bone formation
We examined the overall development and mineralization of the skeleton in CasR ϩ/ϩ , CasR ϩ/Ϫ , and CasR Ϫ/Ϫ mice by Alizarin red S and Alcian blue staining of mineralized bone and cartilage (Fig. 1, A and B, and Fig. 2 ). We observed no differences between CasR ϩ/Ϫ and CasR ϩ/ϩ mice (data not shown). In contrast, we observed profound rachitic changes (Fig. 2, B , D, and F) and delayed endochondral bone formation (Fig. 2, H and J) in CasR Ϫ/Ϫ mice compared to wild-type controls (Fig. 2, A, C , E, G, and I). These changes were observed in 2-and 6-d-old mice. These consisted predominantly of a widening of the metaphyseal regions of long bone, ribs, caudal vertebrae, sternum, and other areas of growth plate cartilage. Ossification of other areas of the skeleton as well as the skeleton's overall appearance were normal in CasR Ϫ/Ϫ mice (Fig. 1B) . In addition, the craniofacial bone appeared normal in CasR Ϫ/Ϫ mice (compare Fig. 1, B and A) . The growth plate of the wrist, the epiphyseal cartilage of the femur, and ventral ribs clearly demonstrate the delay in endochondral bone formation in the CasR Ϫ/Ϫ mice (Fig. 2 , B and D, and F) compared with CasR ϩ/ϩ controls (Fig. 2 , A and C and D). Consistent with the skeletal radiographs (Fig. 1, C  and D) , the wrist of CasR Ϫ/Ϫ demonstrated widened growth plate compared with CasR ϩ/ϩ (compare Fig. 2, B and A) . Secondary ossification of the femoral epiphysis was also delayed in 6-d-old CasR Ϫ/Ϫ compared with CasR ϩ/ϩ mice (compare Fig. 2, D and C) . Similarly, secondary mineralization centers were observed in ventral ribs in CasR ϩ/ϩ mice by 6 d of age, whereas no mineralization was observed in the ribs in CasR Ϫ/Ϫ mice. The ventral ribs also showed classic rachitic rosary in CasR Ϫ/Ϫ , giving a beaded appearance to the cartilage (Fig. 2F ) compared with the normal appearing rib cartilage of CasR ϩ/ϩ mice (Fig. 2E) . The sternum was not mineralized in CasR Ϫ/Ϫ mice (Fig. 1B) . Skeletal development is recapitulated in the postnatal period in the mouse tail vertebra and is characterized by an orderly caudal progression of endochondral bone formation that can be quantified in Alizarin red-and Alcian bluestained skeletal preparations. We characterized the temporal aspects of endochondral bone formation in tail vertebrae these mice. Representative Alizarin red-and Alcian bluestained cleared tail preparations from CasR ϩ/ϩ and CasR mice are shown in Fig. 2 , G-J. In CasR ϩ/ϩ we observed a time-dependent progressive sequence of mineralization of tail vertebrae, such that an average of 24.3 Ϯ 0.5 of the 29 caudal vertebrae had mineralized by d 6 (Fig. 2, G and I) . We observed no significant delay in the mineralization of caudal vertebrae in CasR ϩ/Ϫ mice, which averaged 22.2 Ϯ 1.3 mineralized vertebra (data not shown). In contrast, we found an average of 11Ϯ 0.6 of 29 mineralized caudal vertebrae in 6-d-old CasR Ϫ/Ϫ mice (Fig. 2, H and J) . In the few animals that survived to d 12, these changes were partially reversed, as evidenced by foci of endochondral ossification in the knees and progression of caudal vertebrae mineralization in
FIG. 3. Nondecalcified histological sections of the tibia in CasR
Ϫ/Ϫ and CasR ϩ/ϩ mice. Toluidine blue-stained section (ϫ200 magnification) of the growth plate from CasR ϩ/ϩ (A) and CasR Ϫ/Ϫ (B) showing the widened zone of hypertrophic chondrocytes (HZ). A lower power view of a Goldner-stained sections (ϫ100 magnification) of the growth plate (GP), the primary spongiosa, and secondary spongiosa of CasR ϩ/ϩ (C) and CasR Ϫ/Ϫ (D) mice. Excess osteoid is present in the trabecular and cortical bone of CasR Ϫ/Ϫ mice. The same section of CasR ϩ/ϩ (E and G) and CasR Ϫ/Ϫ (F and H) metaphyseal bone at a higher magnification (ϫ400) showing normal bone marrow and the absence of peritrabecular fibrosis in CasR Ϫ/Ϫ mice (F and H), multinucleated osteoclasts resorbing bone in both CasR ؉/؉ (E) and CasR Ϫ/Ϫ mice (F), normal osteoid seam thickness covered with osteoblasts in CasR ϩ/ϩ mice (G), and widened osteoid seams and hypertrophic osteoblasts in CasR Ϫ/Ϫ mice (H). All sections represent tibial bone cut at the midsagittal level from 4-d-old mice. In Goldner-stained sections mineralized bone is blue, unmineralized osteoid is reddish-brown, and the growth plate is weakly stained. The growth plate is dark blue in the toluidine blue-stained sections.
CasR
Ϫ/Ϫ mice. Nevertheless, the extent of caudal vertebrae mineralization remained significantly less in 12-d-old CasR Ϫ/Ϫ compared with CasR ϩ/ϩ mice (24 Ϯ 0.25 vs. 28 Ϯ 0.2; P ϭ 0.001).
Histological analysis
The earliest time point that we evaluated was 2 d, although detailed analysis was performed in 5-d-old mice to permit the administration of fluorescent labels. The overall gross features of neonatal bone in both CasR Ϫ/Ϫ and CasR ϩ/ϩ mice included a distinct bone cortex, a well developed marrow cavity with a primary and secondary spongiosa, and an adjacent growth plate merging with a cartilaginous epiphysis. The growth plate in CasR Ϫ/Ϫ mice was widened compared with that in CasR ϩ/ϩ littermates (compare Fig. 3 , B and A), consistent with the observed rachitic changes in skeletal radiographs and Alcian blue-stained skeletal preparations. Growth plate enlargement was mainly due to an increased height of the hypertrophic zone ( Table 2 ). The width of the hypertrophic zone was approximately twice as wide in CasR Ϫ/Ϫ compared with CasR ϩ/ϩ mice ( Table 2) due to a greater number of chondrocytes in this zone rather than an increase in cell size or extracellular matrix. Indeed, five to seven cell layers constituted the hypertrophic zone in CasR ϩ/ϩ growth plates, whereas the zone of hypertrophic chondrocytes extended to greater than 15 cell layers in CasR Ϫ/Ϫ mice. The widths of the proliferative and resting zones were not different between CasR Ϫ/Ϫ and CasR ϩ/ϩ mice ( Table 2 ). In addition, examination of the zone of calcified cartilage and primary spongiosa under fluorescent light in mice labeled with calcein (Fig. 4) demonstrated a normal pattern of mineralization in CasR ϩ/ϩ (Fig. 4C) , but a significant reduction in mineralized cartilage and bone in CasR Ϫ/Ϫ mice (Fig. 4D) . The growth plate and calcified cartilage in CasR ϩ/Ϫ mice were indistinguishable from those in CasR ϩ/ϩ mice (data not shown). The histological pattern of a widened zone of hypertrophic-like chondrocytes in CasR Ϫ/Ϫ mice is consistent with the widening of the growth plates observed by Alizarin red S/Alcian blue-stained whole skeletons (Fig. 2) .
Importantly, the metaphyseal border of the calcified cartilage zone, except for the decrease in calcein label in CasR Ϫ/Ϫ mice, was not different between the CasR ϩ/ϩ and CasR Ϫ/Ϫ animals. In particular, the parallel array of capillary loops invading the primary spongiosa and the congregation of putative chondroclasts and mononuclear cells were similar in both CasR ϩ/ϩ and CasR Ϫ/Ϫ metaphyseal junctions (Fig. 3,  C and D) .
The undecalcified bone histology of the trabecular and cortical bone from the tibial metaphysis of CasR ϩ/ϩ and CasR Ϫ/Ϫ mice also is shown in Figs. 3 and 4 . The most striking finding was the excessive amounts of osteoid in CasR Ϫ/Ϫ (Fig.  3, D and H) compared with CasR ϩ/ϩ littermates (Fig. 3, C and  G) . The relative osteoid volume was 7-fold greater in CasR Ϫ/Ϫ compared with CasR ϩ/ϩ mice ( Table 2 ). This increase in osteoid volume in CasR Ϫ/Ϫ mice was due both to a 3-fold increased extent of osteoid covered bone surfaces, or OS/BS (Table 2 and Fig. 3D ), and to a 4-fold increase in the osteoid seam width, or O.Th (Table 2 and Fig. 3H ). Approximately half of the trabecular bone surface was covered with osteoid in CasR Ϫ/Ϫ mice (Fig. 3, F and H, and Fig. 4B ), whereas CasR ϩ/ϩ mice displayed a normal osteoid surface (e.g. ϳ17%; Fig. 3 , E and G, and Fig. 4A ). This hyperosteoidosis in CasR Ϫ/Ϫ mice is consistent with the reduction in dry ashed weight in these animals compared with CasR ϩ/ϩ mice ( Table  1 ). This increase in osteoid was the result of impaired mineralization, as evidenced by the marked reduction in surfaces undergoing mineralization (Table 2 and Fig. 4, D and F) in CasR Ϫ/Ϫ mice. Compared with the normal percentage of mineralizing surfaces (Fig. 4C) and number of double labeled surfaces (Fig. 4E) in CasR ϩ/ϩ mice, the osteoid surfaces of CasR Ϫ/Ϫ mice either exhibited no calcein label or a diffuse band of calcein at the bone-osteoid interface (Fig. 4, D and F) . These are classic histological features of osteomalacia. Indeed, the mineralization lag time exceeded 100 d in CasR Ϫ/Ϫ mice, consistent with the presence of osteomalacia ( Table 2) . As a consequence, the bone formation rate was suppressed in CasR Ϫ/Ϫ mice (Table 2 ) despite the excess circulating PTH levels that typically stimulate mineralized bone formation rates.
We observed an increase in the number of osteoblasts in CasR Ϫ/Ϫ mice due to the greater percentage of osteoid covered surfaces (Table 2 ). In addition the morphology of the osteoblasts in CasR Ϫ/Ϫ displayed a tendency to be transformed from the normal cuboidal form to an irregular polygonal morphology that is typically seen with PTH excess (Fig. 3H) . We also observed entrapment of individual osteoblasts/osteocytes in the osteoid of CasR Ϫ/Ϫ mice, consistent with the presence of woven osteoid in the animals (Fig. 3H) . Interestingly, despite the elevated PTH in CasR Ϫ/Ϫ mice, their bone marrow had no peritrabecular fibrosis, a finding that is commonly observed in PTH excess states. The resorptive surfaces and osteoclastic number were also similar in the CasR ϩ/ϩ and CasR Ϫ/Ϫ mice ( Table 2 and Fig. 3 , E and F), but the osteoclast morphology in CasR Ϫ/Ϫ exhibited giant osteoclasts with several nuclei and prominent nucleoli that are typical in hyperparathyroid bone disease. 
CasR expression in bone, cartilage, and bone marrow
We used two different primer sets to amplify the 5Ј-end and 3Ј-end of the CasR cDNA sequence to evaluate CasR expression in bone, bone marrow, and cartilage. As a positive control we amplified CasR from RNA derived from mouse kidney. The RT-PCR results were identical with the two primer sets. The results from the primer set that amplifies the 5Ј-end of CasR are shown in Fig. 5 . We successfully amplified the predicted 914-bp product in kidney, bone marrow, and cartilage (Fig. 5A) . In contrast, we failed to amplify CasR in bone (Fig. 5A) . To assure that the bone sample contained osteoblasts, we tested the bone-derived RNA for osteocalcin expression. Using osteocalcin-specific primers, we were able to amplify the predicted size product from bone (Fig. 5B) .
Osteocalcin also was present in bone marrow, but to a lesser extent (Fig. 5B) . As a control for RNA integrity, we successfully amplified G3PDH transcripts from all tissues (Fig. 5, A  and B) .
Discussion
We studied the CasR null mouse model to find support for the hypothesis that the calcium-sensing receptor has a direct role in regulating bone and cartilage function in vivo. The predominant skeletal abnormalities in neonatal CasR Ϫ/Ϫ mice were growth retardation and rickets, which is a disorder of impaired extracellular matrix mineralization of the growth plate and newly formed trabecular and cortical bone. Several findings support the presence of impaired mineralization in CasR Ϫ/Ϫ mice. First, radiographic studies and whole skeletal preparations show specific evidence for delayed endochondral ossification in epiphysis and metaphysis of long bones as well as impaired mineralization of other sites. Second, the dry ashed weight also was lower in CasR Ϫ/Ϫ mice consistent with decreased bone density due to excess osteoid accumulation. Finally, histological evaluation of CasR Ϫ/Ϫ mice identified poor mineralization of cartilage and a widened zone of hypertrophic chondrocytes in the growth plate and impaired mineralization of extracellular matrix in both cortical and trabecular bone. Although growth retardation in these animals has been previously described (5) , the presence of rickets in CasR Ϫ/Ϫ mice is an unexpected finding. The etiology of the rachitic changes is not clear. The early appearance of rachitic changes in 2-d-old CasR Ϫ/Ϫ mice is too soon for nutritional and/or vitamin D deficiencies to man- 
ifest. Although CasR
Ϫ/Ϫ mice have severe hyperparathyroidism accompanied by hypercalcemia, hypophosphatemia, few of the phenotypic changes of the skeleton in CasR Ϫ/Ϫ resemble the anticipated skeletal effects of PTH excess. For example, CasR Ϫ/Ϫ mice appear to have a more selective enlargement of hypertrophic zone of the growth plate, whereas transgenic mice models of PTH/PTHrP overactivity typically have increases in both proliferative and hypertrophic chondrocytes (29 -34) . Also, neonatal transgenic mice expressing constitutively active PTH/PTHrP receptors exhibit a profound inhibition of endochondral bone formation, leading to the absence of a normal marrow space and defined metaphyseal bone (31), whereas CasR Ϫ/Ϫ mice have a grossly normal skeletal architecture with a clearly demarcated primary and secondary spongiosa and a normal appearing bone marrow cavity. More importantly, hyperparathyroidism, in the absence of hypocalcemia and vitamin D deficiency, does not typically cause rickets or osteomalacia in metaphyseal bone (35, 36) . Rather, PTH typically stimulates osteoblast and osteoclast activity, leading to accelerated mineralized bone formation rates, bone resorption, and bone marrow fibrosis (37) . The severity of the rachitic changes and the absence of the typical skeletal changes induced by PTH excess support a more complex pathophysiology of these skeletal alterations in CasR Ϫ/Ϫ mice that may involve a skeletal calcium-sensing receptor-like mechanism.
A direct role for calcium in mediating the mineralization process in not a novel concept. Recent observations in VDR null mice demonstrate a direct role of calcium in the pathogenesis of rickets, as evidenced by the ability of calcium to correct the mineralization abnormalities in the absence of a functional VDR (35, 36) . Except for the growth retardation, the bone and growth plate abnormalities in CasR Ϫ/Ϫ mice resemble the calcium-responsive lesion in hypocalcemic VDR null mice (35, 36) . As extracellular fluid supersaturates the calcification of crystal hydroxyapatite, the selective mineralization of bone and cartilage must be regulated by additional organic factors that modulate the mineralization process (38) . Our studies raise the interesting possibility the extracellular calcium-sensing receptor in cartilage and bone marrow may regulate this process. The possibility that a calcium-sensing receptor expressed in the skeleton has a direct role in regulating skeletal mineralization will require further proof. It would be interesting in future studies to evaluate the effects of extracellular calcium to regulate the osteoblast and/or chondrocyte production of mineralization modulators or to regulate matrix vesicle function.
On the other hand, our findings are inconsistent with some of the prevailing ideas regarding the possible role of the skeletal calcium receptor as predicted by in vitro studies. For example, in cell culture models extracellular calcium inhibits osteoclastic activity and stimulates osteoblastic proliferation and chemotaxis. Consequently, the absence of CasR in osteoclasts is predicted to stimulate osteoclastogenesis, whereas the lack of CasR in preosteoblasts or marrow stromal cells should inhibit osteogenesis (1, 15, 16, 39) . In the current studies we failed to find support for CasR regulation of osteoclast activity and osteoblast recruitment, but found multinucleated osteoclasts and increased osteoblast-covered bone-forming surfaces in CasR Ϫ/Ϫ mice. Despite our unexpected and compelling findings, we cannot establish a direct role for CasR in the skeleton based on our current investigations. Our results are confounded by the severe hyperparathyroidism and the accompanying hypercalcemia and hypophosphatemia. Also, because of the early mortality of CasR Ϫ/Ϫ mice, our findings are limited to the neonatal skeleton. Extrapolating a role for CasR to the adult skeleton awaits additional studies in CasR Ϫ/Ϫ mice lacking excess PTH, which may allow them to survive to adulthood. In addition, implicating a direct role for CasR in the skeleton is potentially complicated by redundant calcium-sensing mechanisms in bone. There is an ongoing controversy as to whether all of the functional responses to cations in osteoblasts and osteoclasts are mediated solely by CasR or whether another CasR-like receptor is present (10, 40 -42) that differs from CasR with regard to cation specificity, response to calcimimetics, and signaling pathways. If so, the seemingly paradoxical idea that some of the osseous changes in CasR Ϫ/Ϫ mice might be mediated by another calcium sensing receptor has validity. In this regard, aluminum, which stimulates the FIG. 5. RT-PCR amplification of mouse CasR mRNA in fractionated bone, bone marrow, cartilage, and kidney. Using mouse-specific CasR primers the predicted size 914-bp product was identified in mouse kidney, bone marrow, and cartilage, but not in mineralized bone (A). The presence of osteoblasts in the bone-derived RNA was confirmed by the amplification osteocalcin whose expression is predominantly in mature osteoblasts (B). G3PDH was amplified as a control.
putative novel osteoblast-sensing receptor, but not CasR (43), causes osteomalacia in both humans and animal models (27, 44) . In addition, in the rare CasR Ϫ/Ϫ mice that survived for 12 d, we observed partial reversal of the mineralization abnormalities in whole skeletal preparations. As these mice were not exposed to different environmental conditions, their longer survival may represent selection of an unspecified genetic trait imparting resistant to the loss of CasR. Consequently, the reversal of their skeletal abnormalities may be related to the osseous effects of these undefined compensatory events and suggest the skeletal abnormalities may be modulated by factors other than CasR itself.
In conclusion, we have observed abnormalities of mineralization of extracellular matrix in CasR Ϫ/Ϫ mice that are not completely explained by excess PTH. We speculate that the ablation of CasR in cartilage and bone marrow, the presence of a novel skeletal CasR, or some unanticipated effects of PTH excess in the absence of CasR may be responsible for the observed mineralization abnormalities in bone and cartilage. The major importance of our current findings is to direct research toward identifying the function of calcium-sensing receptors in the skeleton. Before any direct consequences of skeletal calcium receptors can be confirmed, additional studies are needed to remove the confounding skeletal effects of PTH in CasR Ϫ/Ϫ mice and to identify the molecular mechanisms and physiological role of the persistence of calcium sensing in CasR Ϫ/Ϫ osteoblasts.
